{
    "organizations": [],
    "uuid": "1bd964ee3f154ed1e44eeb2210eef0fbbb416fa4",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-gileads-kite-announces-new-facilit/brief-gileads-kite-announces-new-facilities-expands-collaboration-with-national-cancer-institute-idUSASO0004TQ",
    "ord_in_thread": 0,
    "title": "BRIEF-Gilead's Kite Announces New Facilities, Expands Collaboration With National Cancer Institute",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "May 15 (Reuters) - Gilead Sciences Inc:\n* KITE ANNOUNCES NEW WORLDWIDE FACILITIES AND EXPANDED COLLABORATION WITH NATIONAL CANCER INSTITUTE TO SUPPORT CELL THERAPY PIPELINE\n* KITE - ANNOUNCED IT HAS LEASED A NEW FACILITY IN NETHERLANDS TO ENGINEER CELL THERAPIES IN EUROPE\n* KITE - FACILITY TO ENGINEER, PRODUCE INNOVATIVE CELL THERAPIES, INCLUDING AXICABTAGENE CILOLEUCEL, A CHIMERIC ANTIGEN RECEPTOR T CELL (CAR T) THERAPY Source text for Eikon: Further company coverage:\nOur Standards: The Thomson Reuters Trust Principles. ",
    "published": "2018-05-15T21:44:00.000+03:00",
    "crawled": "2018-05-16T19:14:35.003+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "may",
        "reuters",
        "gilead",
        "science",
        "inc",
        "kite",
        "announces",
        "new",
        "worldwide",
        "facility",
        "expanded",
        "collaboration",
        "national",
        "cancer",
        "institute",
        "support",
        "cell",
        "therapy",
        "pipeline",
        "kite",
        "announced",
        "leased",
        "new",
        "facility",
        "netherlands",
        "engineer",
        "cell",
        "therapy",
        "europe",
        "kite",
        "facility",
        "engineer",
        "produce",
        "innovative",
        "cell",
        "therapy",
        "including",
        "axicabtagene",
        "ciloleucel",
        "chimeric",
        "antigen",
        "receptor",
        "cell",
        "car",
        "therapy",
        "source",
        "text",
        "eikon",
        "company",
        "coverage",
        "standard",
        "thomson",
        "reuters",
        "trust",
        "principle"
    ]
}